ARCHIVES

Rep. Wyden Questions NCI Motive For Choosing Not To Pursue RU 486

This article is from The Cancer Letter archive.

Vol. 18 No. 34 | September 4, 1992

Download PDF Visit The Full Archive

Related Articles

NTP Board Okays concept for New In Vitro study Using Oncogenes

May 10, 1985

Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies

November 28, 2014

Draft Report Outlines New Toxicological Test Criteria

November 24, 1995

Max Wicha Describes Michigan’s Restructuring Planning For Growth

May 7, 1999

DCT Board Approves Concept Of Planning Grants For New Particle Therapy Equipment Development

August 7, 1981

NCI To Begin Study of Augmentation Mammoplasty This Fall

May 8, 1992